5 Einträge gefunden

1. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials

   1. Furlanetto, Jenny
   2. Marmé, Frederik
   3. Seiler, Sabine
   4. Thode, Christian
   5. Untch, Michael
   6. Schmatloch, Sabine
   7. Schneeweiss, Andreas

   2021 - Forschungsinformationssystem des UKE
2. DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

   1. Jurmeister, Philipp
   2. Weber, Karsten
   3. Villegas, Sonia
   4. Karn, Thomas
   5. Untch, Michael
   6. Thieme, Anne
   7. Müller, Volkmar

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Ovarian Cancer-Specific BRCA-like Copy-Number Aberration Classifiers Detect Mutations Associated with Homologous Recombination Deficiency in the AGO-TR1 Trial

   1. Schouten, Philip C
   2. Richters, Lisa
   3. Vis, Daniel J
   4. Kommoss, Stefan
   5. van Dijk, Ewald
   6. Ernst, Corinna
   7. Kluin, Roelof J C

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial

   1. Jank, Paul
   2. Gehlhaar, Claire
   3. Lederer, Bianca
   4. Fontanella, Caterina
   5. Schneeweiss, Andreas
   6. Karn, Thomas
   7. Marmé, Frederik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer

   1. Sinn, Bruno V
   2. Loibl, Sibylle
   3. Hanusch, Claus A
   4. Zahm, Dirk-Michael
   5. Sinn, Hans-Peter
   6. Untch, Michael
   7. Weber, Karsten

   2021 - Forschungsinformationssystem des UKE - frei zugänglich